In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the ... trading as the trade war escalates between the US and China. Trump’s tariff bonanza doesn’t look set to ...

The AI chip maker’s shares rose more than 5% after hours as quarterly revenue surged to a record $44 billion.

China has embraced CRISPR gene editing, leapfrogged the West in cell therapy, developed sophisticated animal models and rapidly expanded its biotech exports from near-zero in 2016 to nearly 30% of ...

But increasingly American venture capitalists are building U.S.-based companies from scratch to test and ultimately seek to commercialize innovative drugs developed in China. Most recently ...

L’Oréal Groupe has backed Chinese biotech start-up Veminsyn to help identify new ingredients and speed up the process of ...

But over the past 10 years, they’ve begun to innovate ... “People were aware that the biotech industry was growing very fast in China, but very few saw it as a real threat to the top US ...

Starting in 2019, Hopewell attracted three new U.S.-based biotech firms — PTC Therapeutics ... American with extensive experience in Greater China who now lives in the U.S., BeiGene agreed ...